Caglar Unal (Çağlar Ünal)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

End Stage Renal Disease

Sentinel Lymph Node

Neoadjuvant Chemotherapy

Top Venues

European journal of breast health

Breast cancer (Dove Medical Press)

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Tuba Kayan Tapan, Filiz Elbüken, Kourosh Yaghouti, Filiz Ağaçayak, Ahmet Serkan Ilgun, Gursel Soybir, Naziye Ak, Çetin Ordu, Enver Ozkurt, Caglar Unal, Sevgi Kurt, Alper Oztürk, Zeynep İyigün Erdoğan, Tomris Duymaz, Vahit Özmen
The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy. European journal of breast health 20 (2) (2024)
Tuba Kayan Tapan, Filiz Elbüken, Kourosh Yaghouti, Filiz Ağaçayak, Ahmet Serkan Ilgun, Gursel Soybir, Naziye Ak, Çetin Ordu, Enver Ozkurt, Caglar Unal, Sevgi Kurt, Alper Oztürk, Zeynep İyigün Erdoğan, Tomris Duymaz, Vahit Özmen
The Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapy. European journal of breast health 20 (2) (2024)
Caglar Unal, Sezer Saglam
Metronomic Temozolomide (mTMZ) and Bevacizumab-The Safe and Effective Frontier for Treating Metastatic Neuroendocrine Tumors (NETs): A Single-Center Experience. Cancers 15 (23) (2023)
Caglar Unal, Gülşah Tunçer, Betül Sadıç Çopur, Kezban Nur Pilanci, Kerem Sadi Okutur, Kanay Yararbaş, Özkan Alan, Abdullah Sakin, Melih Simsek, İpek Özönder Ünal, Atakan Topçu, Zeynep Alaca Topçu, Tomris Duymaz, Çetin Ordu
Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020-2022). Current medical research and opinion (2023)
Caglar Unal, Tolga Ozmen, Çetin Ordu, Cihan Uras, Halil Kara, Erhan Gökmen, Mustafa Özdoğan, Orhan Demircan, Kezban Nur Pilancı, Tomris Duymaz, Vahit Özmen
Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk Categorization. European journal of breast health 19 (4) (2023)
Caglar Unal, Tolga Özmen, Ahmet Serkan İlgün, Çetin Ordu, Enver Özkurt, Naziye Ak, Gül Alço, Zeynep Erdoğan İyigün, Sevgi Kurt, Tomris Duymaz, Mehmet Alper Öztürk, Filiz Elbüken Çelebi, Kanay Yararbaş, Gürsel Soybir, Fatma Aktepe, Vahit Özmen
MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification. Breast cancer (Dove Medical Press) 15 (2023)
Caglar Unal, Abdulmunir Azizy, Senem Karabulut, Didem Taştekin, Arif Akyıldız, Serkan Yaşar, Şuayib Yalçın, Eyüp Çoban, Türkkan Evrensel, Ziya Kalkan, Zeynep Oruç, Sümeyra Derin, Zeynep Hande Turna, Doğan Bayram, Fahriye Tuğba Köş, Mehmet Ali Nihat Şendur, Nadiye Sever, Özlem Ercelep, Mustafa Seyyar, Umut Kefeli, Kazım Uygun, Melike Özçelik, Sercan Ön, Ulus Ali Şanlı, Kübra Canaslan, İlkay Tuba Ünek, Kadriye Bir Yücel, Nuriye Özdemir, Ozan Yazıcı, Halil Göksel Güzel, Derya Kıvrak Salim, Sema Sezgin Göksu, Ali Murat Tatlı, Çetin Ordu, Oğuzhan Selvi, Abdullah Sakin, Mehmet Emin Büyükbayram, Bengü Dursun, Yüksel Ürün, Hacı Arak, Gözde Ağdaş, Muzaffer Uğraklı, Engin Hendem, Melek Karakurt Eryılmaz, Burak Bilgin, Atakan Topçu, Melih Şimşek, Mahmut Büyükşimşek, Büşra Akay, Gülçin Şahingöz Erdal, Fatih Karataş, Özkan Alan, Melek Çağlayan, Fatma Akdağ Kahvecioğlu, Ayşe Demirci, Nail Paksoy, Bülent Çetin, Mahmut Gümüş, Naziye Ak, Yasemin Aydınalp, Semra Paydaş, Deniz Can Güven, Saadettin Kılıçkap, Sezer Sağlam
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group. The oncologist (2023)
Caglar Unal, Çetin Ordu, Tolga Özmen, Ahmet Serkan İlgun, Filiz Çelebi, Bülent Baysal, Enver Ozkurt, Tomris Duymaz, Zeynep Erdoğan İyigün, Sevgi Kurt, Mehmet Alper Öztürk, Kezban Nur Pilancı, Tuba Kayan Tapan, Kanay Yararbaş, Tuba Kayan Tapan, Deniz Can Guven, Gürsel Soybir, Vahit Özmen
Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study. Current oncology (Toronto, Ont.) 30 (10) (2023)
Ahmet Serkan Ilgun, Fatma Aktepe, Onur Gonullu, Fatma Nilgun Kapucuoglu, Kanay Yararbaş, Tuba Kayan Tapan, Alper Oztürk, Filiz Elbüken, Zeynep İyigün Erdoğan, Çetin Ordu, Caglar Unal, Tomris Duymaz, Gursel Soybir, Ekrem Yavuz, Sitki Tuzlali, Vahit Özmen
The effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes in patients with breast cancer. Future oncology (London, England) 18 (29) (2022)